Gooding AJ[au] - Search Results

Year	Number of Results
2010	1
2014	1
2015	1
2016	2
2017	1
2018	1
2019	3
2020	2
2021	1
2022	0

1

Epithelial-Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance.

Gooding AJ, Schiemann WP. Gooding AJ, et al. Mol Cancer Res. 2020 Sep;18(9):1257-1270. doi: 10.1158/1541-7786.MCR-20-0067. Epub 2020 Jun 5. Mol Cancer Res. 2020. PMID: 32503922 Free PMC article. Review.

2

lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing α6 Integrin/CD49f Expression in Breast Cancer Stem Cells.

Parker KA, Gooding AJ, Valadkhan S, Schiemann WP. Parker KA, et al. Among authors: gooding aj. Mol Cancer Res. 2021 Dec;19(12):2068-2080. doi: 10.1158/1541-7786.MCR-21-0137. Epub 2021 Sep 8. Mol Cancer Res. 2021. PMID: 34497119 Free PMC article.

3

SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness.

Robinson NJ, Morrison-Smith CD, Gooding AJ, Schiemann BJ, Jackson MW, Taylor DJ, Schiemann WP. Robinson NJ, et al. Among authors: gooding aj. Life Sci Alliance. 2020 Feb 18;3(4):e201900427. doi: 10.26508/lsa.201900427. Print 2020 Apr. Life Sci Alliance. 2020. PMID: 32071280 Free PMC article.

4

The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence.

Gooding AJ, Zhang B, Jahanbani FK, Gilmore HL, Chang JC, Valadkhan S, Schiemann WP. Gooding AJ, et al. Sci Rep. 2017 Oct 5;7(1):12698. doi: 10.1038/s41598-017-12716-6. Sci Rep. 2017. PMID: 28983112 Free PMC article.

5

The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers.

Gooding AJ, Zhang B, Gunawardane L, Beard A, Valadkhan S, Schiemann WP. Gooding AJ, et al. Oncogene. 2019 Mar;38(12):2020-2041. doi: 10.1038/s41388-018-0586-4. Epub 2018 Nov 22. Oncogene. 2019. PMID: 30467380 Free PMC article.

6

The IncRNA BORG: A novel inducer of TNBC metastasis, chemoresistance, and disease recurrence.

Gooding AJ, Parker KA, Valadkhan S, Schiemann WP. Gooding AJ, et al. J Cancer Metastasis Treat. 2019;5:41. doi: 10.20517/2394-4722.2019.11. Epub 2019 May 10. J Cancer Metastasis Treat. 2019. PMID: 31435529 Free PMC article.

7

Zinc Deficiency-induced Hypogeusia in a Patient with Refractory Iron-deficiency Anemia: A Case Report.

Gooding AJ, Packer CD, Pensiero AL. Gooding AJ, et al. Cureus. 2019 Dec 12;11(12):e6365. doi: 10.7759/cureus.6365. Cureus. 2019. PMID: 31938647 Free PMC article.

8

Construction and characterization of a sox9b transgenic reporter line.

Plavicki JS, Baker TR, Burns FR, Xiong KM, Gooding AJ, Hofsteen P, Peterson RE, Heideman W. Plavicki JS, et al. Among authors: gooding aj. Int J Dev Biol. 2014;58(9):693-9. doi: 10.1387/ijdb.140288jp. Int J Dev Biol. 2014. PMID: 25896205 Free PMC article.

9

Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cells.

Gooding AJ, Schiemann WP. Gooding AJ, et al. Transl Cancer Res. 2016 Aug;5(Suppl 2):S226-S232. doi: 10.21037/tcr.2016.08.09. Transl Cancer Res. 2016. PMID: 28680830 Free PMC article. No abstract available.

10

Analysis of the zebrafish sox9b promoter: Identification of elements that recapitulate organ-specific expression of sox9b.

Burns FR, Lanham KA, Xiong KM, Gooding AJ, Peterson RE, Heideman W. Burns FR, et al. Among authors: gooding aj. Gene. 2016 Mar 10;578(2):281-9. doi: 10.1016/j.gene.2015.12.041. Epub 2015 Dec 23. Gene. 2016. PMID: 26721460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results